Zolbetuximab-clzb: Revision history

15 April 2025

• curprev 16:3716:37, 15 April 2025 Parth Vikram Singh talk contribs 32,109 bytes −16 No edit summary
• curprev 16:3416:34, 15 April 2025 Parth Vikram Singh talk contribs 32,125 bytes +7,143 No edit summary
• curprev 16:1216:12, 15 April 2025 Parth Vikram Singh talk contribs 24,982 bytes −1 No edit summary
• curprev 15:5615:56, 15 April 2025 Parth Vikram Singh talk contribs 24,983 bytes +10,908 No edit summary
• curprev 15:3515:35, 15 April 2025 Parth Vikram Singh talk contribs 14,075 bytes +2,198 No edit summary
• curprev 15:3015:30, 15 April 2025 Parth Vikram Singh talk contribs 11,877 bytes +9,551 No edit summary
• curprev 12:4312:43, 15 April 2025 Parth Vikram Singh talk contribs 2,326 bytes +1,347 No edit summary

13 April 2025

• curprev 16:2316:23, 13 April 2025 Parth Vikram Singh talk contribs 979 bytes +979 Created page with "{{DrugProjectFormSinglePage |authorTag={{PVS}} |indicationType=treatment |blackBoxWarningTitle='''<span style="color:#FF0000;">TITLE</span>''' |blackBoxWarningBody=''<span style="color:#FF0000;">Condition Name:</span>'' (Content) |offLabelAdultGuideSupport=There is limited information regarding ''Off-Label Guideline-Supported Use'' of Zolbetuximab-clzb in adult patients. |offLabelAdultNoGuideSupport=There is limited information regarding ''Off-Label Non–Guideline-Suppo..."